Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism

G. C. Farrell, W. G.E. Cooksley, P. Hart, L. W. Powell

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Antipyrine half-life (AP t1/2) was measured in 62 patients with, and 10 control patients without, liver disease to ascertain possible factors which may be useful in identifying patients with abnormal drug metabolism. Antipyrine metabolism was normal or marginally impaired in patients with compensated cirrhosis or acute hepatitis, whereas it was frequently abnormal in those with chronic active hepatitis or advanced alcoholic liver disease. A high degree of correlation was found among AP t1/2 and prothrombin time, hepatic encephalopathy, and ascites. Of patients with severely impaired drug metabolism, 80% had one or more of these features. The severity of histological changes in liver biopsies was of additional help in predicting impaired drug metabolism. Concurrent drug ingestion enhanced antipyrine metabolism in most patients with liver disease as well as in control patients. Inadequate diet was associated with prolongation of AP t1/2, but other environmental factors such as alcohol ingestion, cigarette smoking, and coffee consumption did not affect rates of drug metabolism in patients with liver disease. Consideration of all of the above factors allows qualitative predictions of the rate of hepatic drug metabolism in patients with liver disease, as assessed by the AP t1/2.

Original languageEnglish
Pages (from-to)580-588
Number of pages9
JournalGastroenterology
Volume75
Issue number4
Publication statusPublished - 1 Dec 1978
Externally publishedYes

Fingerprint

Liver Diseases
Liver
Pharmaceutical Preparations
Antipyrine
Eating
Alcoholic Liver Diseases
Hepatic Encephalopathy
Prothrombin Time
Coffee
Chronic Hepatitis
Ascites
Hepatitis
Half-Life
Fibrosis
Smoking
Alcohols
Diet
Biopsy

Cite this

Farrell, G. C. ; Cooksley, W. G.E. ; Hart, P. ; Powell, L. W. / Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism. In: Gastroenterology. 1978 ; Vol. 75, No. 4. pp. 580-588.
@article{00b09e74fa1842048dc64f1bc999184c,
title = "Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism",
abstract = "Antipyrine half-life (AP t1/2) was measured in 62 patients with, and 10 control patients without, liver disease to ascertain possible factors which may be useful in identifying patients with abnormal drug metabolism. Antipyrine metabolism was normal or marginally impaired in patients with compensated cirrhosis or acute hepatitis, whereas it was frequently abnormal in those with chronic active hepatitis or advanced alcoholic liver disease. A high degree of correlation was found among AP t1/2 and prothrombin time, hepatic encephalopathy, and ascites. Of patients with severely impaired drug metabolism, 80{\%} had one or more of these features. The severity of histological changes in liver biopsies was of additional help in predicting impaired drug metabolism. Concurrent drug ingestion enhanced antipyrine metabolism in most patients with liver disease as well as in control patients. Inadequate diet was associated with prolongation of AP t1/2, but other environmental factors such as alcohol ingestion, cigarette smoking, and coffee consumption did not affect rates of drug metabolism in patients with liver disease. Consideration of all of the above factors allows qualitative predictions of the rate of hepatic drug metabolism in patients with liver disease, as assessed by the AP t1/2.",
author = "Farrell, {G. C.} and Cooksley, {W. G.E.} and P. Hart and Powell, {L. W.}",
year = "1978",
month = "12",
day = "1",
language = "English",
volume = "75",
pages = "580--588",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "Elsevier BV",
number = "4",

}

Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism. / Farrell, G. C.; Cooksley, W. G.E.; Hart, P.; Powell, L. W.

In: Gastroenterology, Vol. 75, No. 4, 01.12.1978, p. 580-588.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism

AU - Farrell, G. C.

AU - Cooksley, W. G.E.

AU - Hart, P.

AU - Powell, L. W.

PY - 1978/12/1

Y1 - 1978/12/1

N2 - Antipyrine half-life (AP t1/2) was measured in 62 patients with, and 10 control patients without, liver disease to ascertain possible factors which may be useful in identifying patients with abnormal drug metabolism. Antipyrine metabolism was normal or marginally impaired in patients with compensated cirrhosis or acute hepatitis, whereas it was frequently abnormal in those with chronic active hepatitis or advanced alcoholic liver disease. A high degree of correlation was found among AP t1/2 and prothrombin time, hepatic encephalopathy, and ascites. Of patients with severely impaired drug metabolism, 80% had one or more of these features. The severity of histological changes in liver biopsies was of additional help in predicting impaired drug metabolism. Concurrent drug ingestion enhanced antipyrine metabolism in most patients with liver disease as well as in control patients. Inadequate diet was associated with prolongation of AP t1/2, but other environmental factors such as alcohol ingestion, cigarette smoking, and coffee consumption did not affect rates of drug metabolism in patients with liver disease. Consideration of all of the above factors allows qualitative predictions of the rate of hepatic drug metabolism in patients with liver disease, as assessed by the AP t1/2.

AB - Antipyrine half-life (AP t1/2) was measured in 62 patients with, and 10 control patients without, liver disease to ascertain possible factors which may be useful in identifying patients with abnormal drug metabolism. Antipyrine metabolism was normal or marginally impaired in patients with compensated cirrhosis or acute hepatitis, whereas it was frequently abnormal in those with chronic active hepatitis or advanced alcoholic liver disease. A high degree of correlation was found among AP t1/2 and prothrombin time, hepatic encephalopathy, and ascites. Of patients with severely impaired drug metabolism, 80% had one or more of these features. The severity of histological changes in liver biopsies was of additional help in predicting impaired drug metabolism. Concurrent drug ingestion enhanced antipyrine metabolism in most patients with liver disease as well as in control patients. Inadequate diet was associated with prolongation of AP t1/2, but other environmental factors such as alcohol ingestion, cigarette smoking, and coffee consumption did not affect rates of drug metabolism in patients with liver disease. Consideration of all of the above factors allows qualitative predictions of the rate of hepatic drug metabolism in patients with liver disease, as assessed by the AP t1/2.

UR - http://www.scopus.com/inward/record.url?scp=0018183160&partnerID=8YFLogxK

M3 - Article

VL - 75

SP - 580

EP - 588

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 4

ER -